760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)

The Department of Veterans Affairs (VA) Veterans Health Administration is seeking to procure five specific strengths of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) facility through Request for Quote (RFQ) 36C77025Q0079. The solicitation is for brand-name pharmaceutical products from AbbVie, with precise quantities ranging from 192 to 1,728 bottles across five different tablet strengths (180mg, 120mg, 90mg, 60-65mg, and 30-32.5mg). Qualified vendors must submit a comprehensive package including a signed SF 1449, pricing schedule, valid state wholesale distributor license, Buy American Act Certificate, and a subcontracting plan if applicable. The VA will evaluate quotes using a comparative assessment of past performance and pricing, with a strict requirement that all pharmaceutical products must have at least one year of shelf life remaining at delivery. The response deadline is December 27, 2024, at 4:00 PM CST, with quotes to be submitted via email to Jennifer.Knight@va.gov.

The procurement is an unrestricted solicitation under NAICS code 325412 with a size standard of 1,300 employees, and there are no specific set-aside designations for this contract. Delivery is mandated within 10 days after receipt of order directly to the VA CMOP Leavenworth facility located in Leavenworth, Kansas. The solicitation is being pursued under FAR 13.5 simplified procedures, with market research confirming AbbVie as the sole manufacturer for these specific thyroid tablet prescriptions. While specific award values are not explicitly stated, the procurement covers multiple line items of pharmaceutical products in varying quantities. The contract appears to be a firm-fixed-price arrangement designed to replenish low stock levels of critical thyroid medication, with AbbVie identified as the only responsible source for these specific brand-name pharmaceutical products.